Introduction
The determination of the complete DNA sequence of vaccinia virus (VV) Copenhagen (Goebel et al., 1990) and most of Western Reserve (WR) [see for references] has enabled a systematic analysis of VV genes which might encode membrane-associated, secreted or glycosylated proteins. Many ORFs predicted to encode proteins with putative signal sequences, hydrophobic membrane-spanning sequences and\or the motif Asn-X-Ser\Thr, the attachment site for N-linked carbohydrate, were identified by these and other analyses (Johnson et al., 1993) . VV proteins with one or more of these properties can be classified into three categories. The first group comprises nonstructural proteins that are secreted from the infected cell. Examples are the vaccinia growth factor (Stroobant et al., 1985) , the N1L gene product (Kotwal et al., 1989) , vaccinia complement protein (Kotwal & Moss, 1988) , the interleukin-1β receptor (Alcamı! & Smith, 1992) , the interferon (IFN)-γ receptor , the IFN-α\β receptor (Symons et al., 1995) and the CC chemokine-binding protein (Patel et al., 1990 ; Alcamı! et al., 1998) . These proteins are nonessential for virus replication in vitro but in most cases affect virus virulence in vivo by interfering with the immune response to infection. The second group contains membrane-associated proteins that are incorporated into the extracellular enveloped virus (EEV) particle. Examples include the A56R (Shida, 1986) , F13L (Hirt et al., 1986) , A34R (Duncan & Smith, 1992) , B5R (Engelstad et al., 1992 ; Isaacs et al., 1992) , A36R (Parkinson & Smith, 1994) and A33R (Roper et al., 1996) gene products. Proteins of the third group associate with membranes of the infected cell but are not present in virus particles. Examples are the A38L integral membrane protein (Parkinson et al., 1995) and the surface antigen encoded by gene B18R (the IFN-α\β receptor) (Ueda et al., 1990) . Several other early cell-surface antigens that have not been mapped to specific genes have been described .
In this paper we have characterized the VV WR A40R gene that previously was called SalF2R . A40R was predicted to encode a membrane-associated protein with amino acid similarity to C-type animal lectins and to the VV A34R protein (Duncan & Smith, 1992) . We show here that the gene is expressed early during infection and encodes a type II membrane glycoprotein that is present on the cell surface but is not incorporated into intracellular mature virus (IMV) or EEV. Loss of the A40R gene does not affect virus plaque size, nor virus virulence in a mouse intranasal model.
Methods
Virus and cells. VV WR was grown and titrated as described previously (Mackett et al., 1985) . CV-1, RK "$ , BS-C-1, TK − 143B, Vero and D980R HeLa cells were grown in Dulbecco's modified Eagle's Medium (DMEM) supplemented with 10 % foetal bovine serum (FBS).
Plasmid construction (i) Plasmids for construction of recombinant VVs (rVVs).
Plasmid pPROF1 containing the A40R ORF and flanking sequences was constructed by cloning a 3525 bp SalI-EcoRI fragment isolated from the SalI F fragment of VV WR (pSalIF) into pUC13. pPROF1 was digested with NsiI to remove a 99 bp fragment of the A40R ORF and treated with T4 DNA polymerase to create blunt termini. This small fragment was replaced with a 2n1 kb EcoRI fragment, that had been treated with Klenow enzyme to create blunt termini, which contained the Escherichia coli guanine phosphoribosyl transferase (Ecogpt) gene linked to the VV 7.5K promoter (Boyle & Coupar, 1988) . This plasmid was called pSAD3G. For expression of the A40R ORF from an IPTG-inducible VV promoter, a copy of the ORF was created by PCR using plasmid pPROF1 as template and oligonucleotides 5h CCCGGATCCATATGAACAAACATAAGACA and 3h CGGGGGATCCTTATATAGTGTAACACGA. Underlined nucleotides represent BamHI and NdeI sites. The PCR product was digested with BamHI and cloned into the BamHI site of plasmid pUC13 to form pSAD3. The A40R ORF was sequenced to confirm the fidelity of the PCR product and then excised with BamHI and cloned into the BamHI site of pPR35 downstream of the IPTG-inducible p4b promoter to form pSAD16. To attach an influenza virus haemagglutinin (HA) epitope tag (YPYDVPDYA) at the C terminus of A40R ORF, a DNA fragment was assembled by splicing by overlap extension (SOE). First, a fragment that contained a 5h XbaI site (underlined), the 150 nucleotides upstream of ORF A40R and the A40R ORF fused to a C-terminal HA tag (underlined) followed by a stop codon was produced by PCR using oligonucleotides 5h GCTCTAGACAAACTCGTAGCTCGCAAGTC and 3h AGCGTAATCAGGCACGTCGTAAGGGTATATAGTAGTGTAAC-ACGAATGCAGTTTG as primers and pSalIF as template. Second, a fragment containing the HA tag (underlined), stop codon and 400 nucleotides downstream of the A40R ORF followed by a HindIII site (underlined) was constructed using oligonucleotides 5h TACGACGTGCCTGATTACGCTTAACAATTACACTACATTTTT-ATCATAC and 3h GCGAAGCTTTTAACAGAAGAATGTATAGTG-GAC as primers and pSalIF as template. These two fragments were spliced together by SOE using the terminal oligonucleotides as primers and finally this fragment was digested with XbaI and HindIII and cloned into pGEM-3zf to form pGEM-A40RHA.
(ii) Expression of the A40R ORF as TrpE-and glutathione S-transferase (GST)-fusion proteins. An EcoRI-BamHI fragment was excised from the replicative form of M13mp18 clone SalF164, which contains nucleotides 682-1008 from the left end of the SalIF fragment , and was cloned into pUC13. The resultant plasmid, pSAD4, was digested with EcoRI, treated with Klenow enzyme and digested with BamHI. The released 340 bp fragment was inserted into pATH1 (Koerner et al., 1991) which had been digested with HindIII, treated with Klenow enzyme and digested with BamHI. The derivative plasmid, pSAD26, contained the C-terminal 83 amino acids of A40R fused to the TrpE protein. To express the A40R ORF as a GST-fusion protein, a DNA fragment containing terminal BamHI sites and the sequences encoding A40R amino acids 1-10 and 55-85 was assembled by PCR using oligonucleotides 5h GCGGGATCCATGAATAAGCA-CAAAACGGACTACGCGGGCTGTCCTACTGACTGGATA and 3h GCGGGATCCTTTGCATGCATTACGTCC as primers and pSalIF as template. The PCR fragment was digested with BamHI and cloned into pGEX-2T (Pharmacia) to form pGEX-A40R.
(iii) Plasmids for in vitro transcription of the A40R ORF. The A40R ORF was excised from pSAD3 as a BamHI fragment and cloned into pGEM-3Zf. Clones were isolated with the ORF under the control of either the T7 or SP6 promoter and were termed pA40R-T7 and pA40R-SP6, respectively. Transcriptional mapping. mRNA was extracted from VVinfected cells early or late during infection and A40R transcripts were identified by Northern blotting and S1 nuclease protection experiments as described previously (Duncan & Smith, 1992) .
Construction of rVVs.
An rVV with 99 bp of the A40R ORF replaced with the Ecogpt gene cassette was constructed by transfection of plasmid pSAD3G into CV-1 VV WR-infected cells. A mycophenolic acid (MPA)-resistant rVV, v∆A40R, was isolated by plaque assay on CV-1 cells as described previously (Falkner & Moss, 1988) . A revertant virus, vRA40R, in which the A40R gene was reinserted into v∆A40R was constructed by transfecting v∆A40R-infected cells with pSalIF and selection of Ecogpt − virus on D980R cells (Kerr & Smith, 1991) in the presence of 1 µg\ml 6-thioguanine (Isaacs et al., 1990 ). An rVV, vindA40R, that contained only an IPTG-inducible version of the A40R ORF, was constructed by transfecting plasmid pSAD16 into v∆A40R-infected TK − 143B cells and selecting thymidine kinase − virus as described (Rodriguez & Smith, 1990 b) . Finally, an rVV (vA40RHA) that contained an HA tag fused to the C terminus of A40R ORF was constructed by transfection of plasmid pGEM-A40RHA into v∆A40R-infected CV-1 cells and selection on D98OR cells in the presence of 6-thioguanine.
Immunoblotting. Antisera to A40R were produced by immunization of rabbits with fusion proteins produced in E. coli. The immunoglobulin (Ig) fraction of the anti-A40R-TrpE serum (called anti-A40R1) was isolated by sodium sulphate fractionation and DEAE chromatography as described (Parkinson & Smith, 1994) . Anti-A40R2 Ig was purified by passing anti-GST-A40R serum through a GST-Sepharose 4B (Pharmacia Biotech) column and then passing the unbound Ig through a GST-A40R-Sepharose column. The bound Ig was eluted in 100 mM glycine (pH 2n5), dialysed against PBS and concentrated. Cells were harvested at the indicated time post-infection (p.i.) and lysates were resolved by SDS-PAGE and transferred electro- Immunofluorescence and confocal microscopy. BS-C-1 cells were grown on glass coverslips and infected with indicated viruses at 1 p.f.u. per cell. At 8 h p.i. the cells were washed in ice-cold PBS and fixed in ice-cold acetone for 1 min. After drying, the cells were blocked in PBS, 5 % FBS, 1 % BSA for 1 h at room temperature and then incubated with mouse monoclonal antibody (MAb) HA1.1 (BAcC0, Berkeley, CA, USA) against the influenza HA tag, or biotinylated mouse MAb AB1.1 against the VV D8L protein (Parkinson & Smith, 1994) . After washing, bound antibody was detected with fluorescein-isothiocyanate (FITC)-conjugated donkey anti-mouse (DAM) or rhodamine-conjugated streptavidin (Rdstrep) (Serotech). For analysis of non-permeabilized cells, the primary MAb was added to cells on ice, unbound MAb was removed by washing and the cells were then fixed in acetone and treated as for permeabilized cells (above). Samples were mounted in 90 % glycerol, 2n5% (w\v) diazabicydo and 10 % PBS and analysed by using a Bio-Red MRC 1024 confocal microscope.
CBDI
In vitro transcription-translation. Plasmids pA40R-T7 and pA40R-SP6 were linearized with SalI and used as templates for synthesis of uncapped transcripts using the Promega riboprobe core system with T7 RNA polymerase. The completed transcription reactions were treated with RNase-free DNase, extracted twice with phenol-chloroform, once with chloroform and precipitated with ethanol. Pelleted RNA was redissolved in nuclease-free water. Translation reactions were performed using the ECL in vitro translation system (Amersham) as directed by the manufacturer. RNA template was used at a concentration of 30 µg\ml and 1n8 µl canine pancreatic microsomal membranes (Promega) were added per 25 µl reaction where indicated. Reactions were incubated for 1 h at 30 mC. Translation products were resolved by SDS-PAGE, transferred to nitrocellulose and biotinylated proteins were detected with streptavidin-conjugated horseradish peroxidase (Vectastain Elite ABC kit, Vector Laboratories) and ECL (Amersham).
Measurement of virus virulence. Groups of 5 female BALB\c mice (5-6-weeks-old) were infected intranasally with 10% or 10& p.f.u. of VV WR, v∆A40R or vRA40R in 20 µl PBS. Animals were weighed daily and those showing more than 30 % loss of original body weight were sacrificed by cervical dislocation.
Results

Sequence analysis
The VV WR SalI F fragment contains an ORF of 159 codons with the potential to encode a membrane-associated glycoprotein that originally was called SalF2R , but hereafter will be referred to as A40R, the name of the equivalent ORF in VV Copenhagen (Goebel et al., 1990) . Near the N terminus of the predicted A40R protein there are 23 hydrophobic amino acid residues which could function as a signal and or anchor sequence. Towards the C terminus a more hydrophilic region contains three potential sites for addition of asparagine-linked carbohydrate (N-X-S\T, where X is any amino acid except P). The predicted protein sequence also contains three threonine-O-glycosylation motifs (Gooley et al., 1991) .
Comparison of the A40R sequence with the SWISS-PROT protein database revealed similarity to several proteins from fowlpox virus (Tomley et al., 1988) , to VV A34R (Duncan & Smith, 1992) and to the family of calcium-dependent (C-type) animal lectins. The C-type lectin superfamily includes selectins that enable lymphocytes to localize at sites of inflammation, collectins that are thought to function in humoral defence by binding to the surface carbohydrates of pathogens, and a number of membrane-bound receptors that mediate endocytosis of glycoproteins (Drickamer, 1993) . These proteins are characterized by one or more carbohydrate-recognition domains (CRD) of 115-130 amino acids including 14 invariant of 32 conserved residues. The crystal structures of the C-type lectin domain of the rat mannose-binding protein and of Eselectin have been determined (Weis et al., 1991 (Weis et al., , 1992 Graves et al., 1994) . The C-type lectins most closely related to A40R are natural killer cell receptors, human low affinity IgE receptor (CD23) and human early lymphocyte activation antigen (CD69). The highest FASTA score (198) with a non-poxvirus protein was against the human natural killer cell G2-A protein (accession no. P26715). A40R conforms well to approximately the first half of the C-type CRD but then differs significantly and overall contains only 5\14 and 17\32 of the invariant and conserved residues, respectively. One of the cysteine residues predicted to form an intradomain disulphide bond and sequences corresponding to loop 2 and β sheet 5 are missing. However, other lectins that lack a number of conserved residues and have deletions in loop regions are still predicted to form a C-type lectin fold and have been demonstrated to bind carbohydrate. Thus it is uncertain if the A40R gene product will have lectin activity. For amino acid alignment of A40R with other poxvirus proteins and several lectins see Duncan & Smith (1992) .
Transcriptional analyses
Downstream of A40R and before the next ORF, A41L, there are three potential sites for termination of early transcription [(T) & NT (Yuen & Moss, 1987) ] in the rightward direction and two in the leftward direction, indicating that transcriptional interference between A40R and A41L is unlikely early during infection. Upstream of A40R, the presence of the sequence AC(A) $ TG(A) ( , which closely resembles the VV early promoter consensus (A) Moss, 1989 a) , and the absence of the sequence TAAAT that is found at the RNA start sites of most late genes (Rosel et al., 1986 ; Davison & Moss, 1989 b) , suggest that A40R might be transcribed early during infection. This prediction was examined experimentally by Northern blotting and S1 nuclease protection analyses of RNA extracted from VV-infected cells either early (6 h in the presence of cycloheximide) or late (16 h) after infection. Fig. 1 (a) shows that a $#P-labelled single-stranded probe complementary to nucleotides 84-411 of the A40R ORF coding strand detected an early transcript of approximately 600 nucleotides and heterogeneous RNAs made late during infection. The latter ob- servation is consistent with the known heterogeneity of late VV mRNAs. These transcripts may, therefore, initiate either from a proximal A40R late promoter or from start sites further upstream. To address this, and to accurately map the 5h end of the early transcript, an S1 nuclease protection experiment was performed using a probe that was labelled at the SphI site 252 nucleotides downstream from the 5h end of the ORF and which extended 614 nucleotides upstream (Fig. 1 b) . This probe was protected partially from S1 nuclease digestion by hybridization to early RNA (lane 2) and the size of the protected RNA 
Disruption of the A40R ORF in the virus genome
To investigate the function of the A40R gene, an rVV (v∆A40R) was constructed in which the ORF was disrupted by insertion of the Ecogpt gene cassette after amino acid 50 so that the entire lectin-like domain of A40R would not be expressed. To ensure that any phenotypic difference seen with v∆A40R was not due to mutations elsewhere in the virus genome, a revertant virus, vRA40R, was made by reinserting the A40R gene at its natural locus. The genomes of the WT, v∆A40R and vRA40R viruses were analysed by PCR and Southern blotting and found to have the predicted structures (data not shown).
Growth properties of v∆A40R
During plaque-purification of v∆A40R there was no apparent difference in the size or morphology of plaques compared to WT. Nevertheless, it was possible that there were slight differences in the virus yield that would not be reflected in plaque size and so the growth kinetics of v∆A40R, WT and vRA40R viruses were compared. After infection of RK "$ cells with 0n1 p.f.u. per cell, the yields of cell-associated virus or virus recovered from the medium of infected cells were indistinguishable for the three viruses (Fig. 2) . Similarly, after infection with 0n001 or 10 p.f.u. per cell there were no differences in virus yields in either RK "$ or CV-1 cells (data not shown).
To compare more accurately the amounts of EEV produced by WT, v∆A40R and vRA40R, RK "$ cells infected at 10 p.f.u. per cell were labelled with [$H]thymidine and the EEV present in the supernatant at 24 h p.i. was measured by caesium chloride density-gradient centrifugation (Parkinson & Smith, 1994) . Similar levels of EEV were produced by v∆A40R, WT and vRA40R infections (data not shown), confirming that the A40R gene is dispensable for the production of normal amounts of either EEV or IMV.
Characterization of A40R protein in infected-cell extracts
Anti-A40R1 Ig was used in immunoblots of extracts from cells infected with either VV WR or v∆A40R. Cells were infected in the presence or absence of cytosine arabinoside (araC), an inhibitor of virus DNA replication and late gene expression, to produce early and late virus proteins, respectively. Proteins that were specific to WR-infected cells were detected in both early and late infected-cell extracts (Fig.  3 a) , consistent with the early transcription of the gene (Fig. 1) , and suggesting either continued translation late during infection or that the protein is stable. Immunoprecipitation of A40R from metabolically labelled infected-cell extracts showed that it is synthesized only at early times of infection and is stable (data not shown). Three major proteins of 28, 35 and 38 kDa were detected early, with the 28 kDa form becoming less abundant late in infection. Longer exposure also revealed a minor protein of 18 kDa at both early and late times. The size of this band is close to that of the predicted primary A40R translation product (18 152 Da) and its abundance increased in the presence of tunicamycin (see below), suggesting that it represented unglycosylated A40R protein.
The detection of multiple protein bands and the presence of potential N-and O-linked glycosylation sites in the A40R amino acid sequence suggested that the protein was glycosylated. To investigate this, immunoblots were performed on extracts from cells infected in the presence of either tunicamycin or monensin, which inhibit glycosylation occurring in the endoplasmic reticulum and trans-Golgi, respectively (Fig.  3 b) . Infection in the presence of tunicamycin blocked the formation of higher molecular mass forms of A40R and only the 18 kDa primary translation product was detected. Treatment with monensin produced A40R bands of intermediate size (27 and 30 kDa), consistent with the prevention of late (trans-Golgi) modifications to the protein.
The lack of expression of WT A40R by v∆A40R is shown in Fig. 3 (a, b, c) . These analyses might not have detected the Nterminal, 50 amino acid peptide predicted to be synthesized by v∆A40R due to its small size, lack of recognition by the antisera or instability. Fig. 3 (c) and 76 kDa, which are possibly dimers of glycosylated A40R (Fig. 3 c) .
A40R partitions with integral membrane proteins in Triton X-114
Triton X-114 partitioning has been used to separate hydrophobic integral membrane proteins from hydrophilic soluble proteins (Bordier, 1981) . Therefore, the partitioning of A40R in Triton X-114 was investigated in infected-cell extracts. An rVV, vindA40R, was used because in the presence of IPTG this virus makes greater amounts of A40R protein than VV WR. The A40R proteins partitioned predominantly to the detergent phase (Fig. 4 a, lane 2) as did the EEV protein B5R, under the same conditions (Fig. 4 b, lanes 2) . In contrast, the soluble VV core protein kinase, B1R, partitioned exclusively to the aqueous phase as expected (Fig. 4 b, lanes 1) . Thus A40R exhibits phase separation characteristics typical of integral membrane proteins.
In vitro translation of A40R
The amino acid sequence of A40R suggests that the protein has type II membrane topology. To address the membrane topology of A40R experimentally, the protein was transcribed and translated in vitro in the presence or absence of canine pancreatic microsomal membranes. In the absence of microsomes an unglycosylated 18 kDa protein was synthesized (Fig.  5 , lane pA40R-T7) that was not evident using a plasmid containing the A40R protein in the reverse orientation (pA40R-SP6). Translation in the presence of microsomal membranes produced two A40R proteins of 35 and 38 kDa, approximately the same size as those seen in infected-cell extracts at late times of infection (compare Fig. 5 (2) phases (Bordier, 1981) . The two phases were made equal in volume, salt and detergent concentration and analysed by SDS-PAGE and immunoblotting using (a) anti-A40R1 Ig (diluted 1/250) or (b) anti-B5R (diluted 1/5000) (Engelstad et al., 1992) and anti-B1R antibodies (diluted 1/250) (Banham & Smith, 1992) . Arrows in (a) indicate the positions of the A40R proteins. Positions of protein size markers are shown in kDa.
(b) (a) Fig. 5 . In vitro transcription and translation of A40R. (a) Synthesis of A40R protein in the absence of microsomal membranes. Translation reactions were performed using RNA transcribed from templates pA40R-T7 or pA40R-SP6 that contain the A40R ORF in the positive or reverse orientation, respectively. A 2n5 µl aliquot of each reaction was mixed with an equal volume of 2iLaemmli buffer, heated at 60 mC for 2 min and resolved by SDS-PAGE (15 % gel) before transfer to nitrocellulose and detection as described in Methods. (b) A40R associated with microsomal membranes is protected from proteinase K digestion. Translation reactions were performed in the presence of microsomal membranes using RNA transcribed from pA40R-T7 (lanes 1-3) or plasmid A40R-SP6 (lanes 4-6). After incubation at 30 mC for 1 h, 6 µl aliquots from each reaction were mixed with 6 µl of either PBS (lanes 1 and 4), 0n1 mg/ml proteinase K in PBS (lanes 2 and 5) or 0n1 % Triton X-100 plus 0n1 mg/ml proteinase K in PBS (lanes 3 and 6) and incubated on ice for 30 min. Proteinase K was inactivated by addition of 2n5 µl 100 mM PMSF before addition of Laemmli buffer and analysis as in (a). Arrows indicate the positions of the A40R proteins. Positions of protein size markers are shown in kDa. Fig. 3 ). Since the potential asparagine-linked glycosylation sites are near the C terminus of the protein, this observation confirmed that the C terminus is within the vesicle. These glycosylated forms of A40R pelleted with the microsomal membranes when the translation-reaction mixtures were centrifuged at 13 000 r.p.m. in a microfuge for 30 min at 4 mC (data not shown), providing further evidence for membrane-or vesicle-association of the A40R proteins.
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A40R proteins synthesized in the presence of microsomes were resistant to proteinase K digestion, but became sensitive after treatment of the membrane-associated translation products with Triton X-100 to lyse the membranes (Fig. 5 b) . No shift in mobility of the membrane-associated proteins was observed in the presence of proteinase K without detergent treatment. This is consistent with only seven amino acids upstream of the putative hydrophobic signal\anchor sequence being exposed to proteinase and even if these residues were digested the difference may have been too small to detect on this gel. Thus the A40R protein is a membrane-associated glycoprotein with type II membrane topology. 
The A40R protein is expressed at the cell surface
The anti-A40R Ig fractions did not work well for immunofluorescence and so the subcellular location of the A40R protein was addressed using an rVV in which the endogenous A40R protein was replaced by A40RHA containing an HA epitope fused to the C terminus. vA40RHA formed a similar sized plaque and produced a similar amount of A40R protein compared to WR virus (data not shown). Cells infected with vA40RHA or WR were stained with MAb against the HA tag before or after membrane permeabilization (Fig. 6 a-c) . The A40RHA protein was detected readily in vA40RHA-infected cells but not in WR-infected cells. In permeabilized cells the A40RHA protein was present in the perinuclear region and punctate cytoplasmic structures that might represent the Golgi network and exocytic vesicles, respectively. In nonpermeabilized cells the A40RHA protein was detected at the cell surface. The recognition of the C-terminal HA tag at this location in non-permeabilized cells confirmed that the C terminus of the A40R protein was outside the cell, consistent with a type II membrane topology.
The A40R protein is not incorporated into virions
To examine if the A40R protein became associated with virions, vA40RHA-infected cells were stained with MAbs to the HA tag or VV protein D8L (Fig. 6 d-f) . Merged images of D8L-positive virions and HA-tag-positive structures showed these were mostly not coincident. Similarly, if intracellular enveloped virus (IEV) and cell-associated enveloped virus (CEV) particles were stained with anti-B5R MAb, the B5R-positive virions were not coincident with HA-positive structures, although some co-localization in the Golgi was evident (data not shown).
As an independent way to assess whether the A40R protein is incorporated into virions, IMV and EEV were purified from WR-infected cells or the culture supernatant by sucrose density-gradient centrifugation and were analysed by immunoblotting. No A40R protein was detected in virions despite these proteins being detected easily in infected-cell extracts (Fig. 7 a) . For comparison, the D8L and B5R proteins were detected at similar levels in infected-cell extracts and virions (Fig. 7 b, c) . The lack of B5R in IMV confirmed the purity of this preparation.
v∆A40R is not attenuated in mice infected intranasally
There are many VV genes that are non-essential for virus replication in vitro but which affect virus virulence in vivo. The virulence of v∆A40R was therefore compared to WT and vRA40R using a murine intranasal model (Turner, 1967) . Fig.  8 shows that animals infected with these viruses at doses of 10% 
Discussion
The VV WR gene A40R is shown to encode a type II membrane glycoprotein that is expressed early during infection and forms higher molecular mass complexes under nonreducing conditions. The protein is expressed on the cell surface but is not incorporated into IMV or EEV particles. A virus with a disrupted A40R ORF replicated normally in vitro and had unaltered virulence in mice that were infected intranasally.
An interesting comparison may be made between the VV A40R and A34R proteins. These two proteins show amino acid similarity to the family of C-type lectins and have a type II membrane topology with the relatively hydrophilic C terminus, including the CRD, positioned on the outside of the cell (Duncan & Smith, 1992) . This topology was confirmed for A40R by glycosylation of the protein translated in vitro in the presence of microsomal membranes, protection of the membrane-associated protein from proteinase K digestion, and detection of the A40RHA protein on the cell surface by MAb directed against the C-terminal HA tag. Similarly, the A34R protein has type II membrane topology as shown by its detection on the EEV surface with a C-terminal specific antibody (Duncan & Smith, 1992) and by in vitro translation in the presence of microsomes and subsequent digestion with proteases (Parkinson et al., 1995) . The A34R and A40R proteins are both glycosylated and form multiple glycoproteins and higher molecular mass complexes. In other respects, however, the proteins differ. A40R is expressed early during infection while A34R is late. A40R was not detected in virions and is present on the surface of the infected cells, while the A34R protein is part of the EEV outer envelope. A40R does not affect virus plaque formation, in vitro replication or virulence in mice, while A34R affects normal plaque formation, EEV release and virus virulence (Duncan & Smith, 1992 ; Blasco et al., 1993 ; McIntosh & Smith, 1996) .
In terms of conservation in orthopoxviruses the two proteins also differ. A comparison of the VV WR A40R to the equivalent protein in VV Copenhagen (Goebel et al., 1990) showed that a frameshift mutation replaces the C-terminal 22 amino acids of WR with 31 unrelated residues in Copenhagen. Immunoblotting showed that VV International Health Department (IHD)-J strain did not express the A40R protein (data not shown) and the sequences of variola viruses Harvey-1947 (Aguado et al., 1992 , India-1967 (Shchelkunov et al., 1995 and Bangladesh-1975 (Massung et al., 1994 show that in each case the A40R gene is disrupted. In contrast, the A34R protein is very highly conserved between these viruses (McIntosh & Smith, 1996) . VV possess other groups of genes encoding proteins that belong to the same protein superfamily but which have different roles in the virus life-cycle, for example the VV proteins belonging to the Ig, complement control protein, serine protease inhibitor and protein kinase superfamilies (Johnson et al., 1993 ; Moss, 1996) . A40R shares amino acid similarity to the CRD domain of Ctype animal lectins. The C-type lectin CRDs have relatively low affinity for their cognate ligands and in some cases this is compensated for by having multiple CRDs in a single polypeptide chain or by having a single CRD linked to an α-helical region that can enable oligomerization via coiled-coil interactions (Drickamer, 1993) . In this regard, it is noteworthy that the A40R protein forms higher molecular mass complexes in the absence of reducing agents. C-type lectins function in a number of processes that constitute the host response to infection and it possible that A40R has, or once had, a role in interfering with one or more of these processes. The low but significant amino acid similarity of A40R to several C-type lectins, particularly the natural killer (NK) cell proteins that recognize class I major histocompatibility complex (MHC) antigens, is intriguing. These NK cell proteins engage class I MHC molecules on other cells and send signals that prevent activation of the NK cell. However, in the absence of class I MHC antigens the NK cell may be activated and kill the target cell. Since the A40R protein would be present on infected cells, rather than NK cells, it is unclear if this protein would be in a position to affect activation of the NK cell. Experiments to investigate these and other possibilities are in progress.
